Amgen to consolidate its digital patient engagement systems under Deloitte banner

Doctor's office
Deloitte will consolidate Amgen's patient services into a single, connected engagement system. (Pixabay)

Amgen has tapped Deloitte to build the foundation of its global digital patient services strategy.

Deloitte will use its cloud-based ConvergeHEALTH Patient Connect platform to consolidate and link the big pharma’s disparate patient services to provide a single, connected engagement system.

"In a complicated, and increasingly difficult-to-navigate healthcare environment, patient-centric services are critical to ensure patients that need Amgen therapeutics are supported in their individual journeys," said Claes Hornstrand, Amgen’s VP for U.S. value and access, in a statement.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The platform includes connected apps and devices aimed at providing digital therapy and disease management, alongside supporting healthcare professionals’ delivery of care. It also offers analytics of treatment outcomes and real-world evidence, and aggregates data from multiple sources.

As Amgen continues to work on treatments for different diseases, Deloitte will help configure its system to better coordinate care.